フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Silence Therapeutics plc (Nasdaq: SLN), a leader in the discovery, development and delivery of novel short interfering ribonucleic acid (siRNA...
Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the Company”), a leader in the discovery, development and delivery of novel short...
– Results were simultaneously presented today in a late breaker at the American College of Cardiology’s 71st Annual Scientific Session (ACC.22...
– SLN360 reduced Lp(a) – a key genetic risk factor for heart disease - by up to 98% with reductions of up to 81% persisting at 150 days –...
Silence to receive $3 million research milestone payment from Mallinckrodt Phase 1 study expected to begin in the first half of 2022 Silence...
– Positive SLN360 data to be presented in late breaker at the American College of Cardiology (ACC) Annual Meeting on April 3, 2022 – SLN124...
Mark Rothera steps down as President and CEO Silence Therapeutics plc, Nasdaq: SLN (“Silence” or “the...
SLN360, an investigational siRNA to reduce risk of Lp(a)-mediated cardiovascular disease, was safe and well tolerated in the study SLN360...
Data to be presented by Professor of Cardiovascular Medicine at the Cleveland Clinic, Steven Nissen, MD, on Sunday April 3, 2022 Silence...
Silence Therapeutics plc (Nasdaq: SLN), a leader in the discovery, development and delivery of novel short...
PLEASANTON, Calif., March 26 /PRNewswire-FirstCall/ -- Polycom, Inc. (NASDAQ:PLCM), the world's leading provider of unified collaborative...
PLEASANTON, Calif., March 21 /PRNewswire-FirstCall/ -- Polycom, Inc. (NASDAQ:PLCM) today announced the expiration of the tender offer by its...
First to Offer SIP-based Wi-Fi and DECT Wireless Telephones Certified with Asterisk Business Edition SAN JOSE, Calif., March 19, 2007...
PLEASANTON, Calif. and BOULDER, Colo., March 12 /PRNewswire-FirstCall/ -- Polycom, Inc. (NASDAQ:PLCM) and SpectraLink Corporation (NASDAQ:SLNK...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約